CRYPTOCOCCOSIS

Clinical trials for CRYPTOCOCCOSIS explained in plain language.

Never miss a new study

Get alerted when new CRYPTOCOCCOSIS trials appear

Sign up with your email to follow new studies for CRYPTOCOCCOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Experimental drug shows promise for rare immune disorders

Disease control Completed

This early-phase study tested the safety of rituximab, a drug that targets faulty white blood cells, in 7 adults with rare immune diseases like pulmonary alveolar proteinosis and severe candidiasis. Participants received several doses over 6 months and were monitored for 18 month…

Matched conditions: CRYPTOCOCCOSIS

Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

CRYPTOCOCCOSIS

Get alerted when new CRYPTOCOCCOSIS trials appear

Experimental drug shows promise for rare immune disorders